-
INDIGENOUS EMERGENCY IN BRAZIL
Fiocruz creates a Situation Room for the Yanomami Indigenous Land
Learn more -
WHO: Fiocruz is one of the world’s 15 main manufacturers of vaccines
The Butantan Institute is also part of the ranking of manufacturers released by the WHO report
Learn more -
The Lancet HIV releases ImPrEP results in Latin America
A reference in the implementation and expansion of pre-exposure prophylaxis (PrEP) to HIV in Brazil, Mexico and Peru, the ImPrEP project just had its main results presented in The Lancet HIV
Learn more -
Fiocruz studies antiviral drug against COVID-19
The substance, named MB-905, was purified from kinetin and has been shown to be effective in inhibiting the replication of Sars-CoV-2 and in helping to halt the inflammatory process triggered by the virus
Learn more -
Mario Moreira is appointed acting president of Fiocruz
Dr Moreira will remain in the position until April 2nd, when a new electoral process will be carried out for the Presidency
Learn more -
Nísia Trindade Lima will be the first woman to head the Brazilian Ministry of Health
The announcement was made on December 22 by president-elect Luiz Inácio Lula da Silva in Brasilia
Learn more -
Civil society and health emergencies
Access the Course and the Policy Brief here.
Learn more
Welcome!
The Oswaldo Cruz Foundation (Fiocruz) is the most prominent Institution of Science and Technology in Health in Latin America, based in Brazil. Its mission is to produce, disseminate and share knowledge and technologies
|
|
|
|
|
||
|
|
|
|
|
|